Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo.
Journal: Dermatology and therapy
Published: August 04, 2025
Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo.
Journal: The Journal of investigative dermatology
Published: July 21, 2025
Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 study.
Journal: The British journal of dermatology
Published: June 25, 2025
Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study.
Journal: The British journal of dermatology
Published: June 25, 2025
Randomized, double-blind treatment withdrawal or continuation with ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 study.
Journal: The British journal of dermatology
Published: June 13, 2025
Efficacy of Topical Botanical Treatment of Children With Mild to Moderate Atopic Dermatitis
Journal: Journal of drugs in dermatology : JDD
Published: October 05, 2019
Validation of Botanical Treatment Efficiency for Adults and Children Suffering from Mild to Moderate Atopic Dermatitis
Journal: Journal of drugs in dermatology : JDD
Published: June 29, 2019
Showing 1-7 of 7
Last Updated: 09/26/2026